Wisdom Financial News App reported that Zyy (08223) announced that on September 27, 2024, the company (buyer) intends to purchase shares of Hongyang Xintian (Shenzhen) Technology Co., Ltd. (target company) that the seller intends to sell.

The target company is a limited company established in China in 2023, dedicated to the research and development, production, and operation of port biosecurity control and treatment technology. It has successfully developed a new generation of quarantine treatment technology 'Fully Automatic Vacuum Steaming Quarantine Treatment Technology' with seven patented technologies.

Directors believe that once the possible acquisition is finalized, it can bring synergies to the group's existing operations. By integrating the resources, channels, and market advantages of the target company and the group, the group will further develop the medical instruments and consumables trading business, enhancing its competitiveness and market position in this field.